Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 05.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 23.10.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointme |
| 10.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoi |
| 05.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App |
| 26.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App |
| 08.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App |
| 08.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App |
| 24.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App |
Stammdaten
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Unternehmen & Branche
| Name | HeartBeam, Inc. |
|---|---|
| Ticker | BEAT |
| CIK | 0001779372 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Information Services |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 29,4 Mio. USD |
| Beta | -0,64 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -21,015,000 | -0.62 | 5,843,000 | 2,603,000 | |
| 2025-09-30 | 10-Q | -5,255,000 | -0.15 | 2,876,000 | 406,000 | |
| 2025-06-30 | 10-Q | -4,974,000 | -0.15 | 5,981,000 | 4,182,000 | |
| 2025-03-31 | 10-Q | -5,484,000 | -0.18 | 9,107,000 | 7,529,000 | |
| 2024-12-31 | 10-K | -19,448,000 | -0.73 | 3,276,000 | 1,654,000 | |
| 2024-09-30 | 10-Q | -4,979,000 | -0.19 | 6,657,000 | 4,801,000 | |
| 2024-06-30 | 10-Q | -4,956,000 | -0.19 | 10,126,000 | 8,706,000 | |
| 2024-03-31 | 10-Q | -4,606,000 | -0.17 | 13,635,000 | 12,538,000 | |
| 2023-12-31 | 10-K | -14,639,000 | -0.72 | 17,131,000 | 15,937,000 | |
| 2023-09-30 | 10-Q | -3,470,000 | -0.13 | 19,648,000 | 18,629,000 | |
| 2023-06-30 | 10-Q | -3,154,000 | -0.16 | 21,062,000 | ||
| 2023-03-31 | 10-Q | -4,136,000 | -0.50 | -859,000 | ||
| 2022-12-31 | 10-K | -12,962,000 | -1.59 | 4,039,000 | 2,374,000 | |
| 2022-09-30 | 10-Q | -3,579,000 | -0.44 | 6,672,000 | 5,740,000 | |
| 2022-06-30 | 10-Q | -3,525,000 | -0.43 | 9,738,000 | 8,968,000 | |
| 2022-03-31 | 10-Q | -2,146,000 | -0.27 | 12,741,000 | 12,227,000 | |
| 2021-12-31 | 10-K | -4,428,000 | -1.03 | 13,998,000 | 13,410,000 | |
| 2021-09-30 | 10-Q | -1,188,000 | -0.32 | 961,000 | -5,187,000 | |
| 2021-06-30 | 10-Q | -945,000 | -0.26 | -4,264,000 | ||
| 2021-03-31 | 10-Q | -210,000 | -0.06 | -4,986,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Ferrari Richard | Director | Open Market Purchase | 57,500 | 0.80 | 46,000.00 | +27,2% | |
| 2026-04-16 | Elfrink Willem | Director | Open Market Purchase | 187,500 | 0.80 | 150,000.00 | +88,8% | |
| 2026-04-16 | JAFF MICHAEL R | Director | Open Market Purchase | 31,250 | 0.80 | 25,000.00 | +14,8% | |
| 2026-04-16 | Vajdic Branislav | Director | Open Market Purchase | 31,250 | 0.80 | 25,000.00 | +14,8% | |
| 2026-04-16 | Ortigas-Wedekind Marga | Director | Open Market Purchase | 25,000 | 0.80 | 20,000.00 | +11,8% | |
| 2026-04-16 | STROME MARK E | Director | Open Market Purchase | 750,000 | 0.80 | 600,000.00 | +355,0% | |
| 2026-04-16 | Ferrari Richard | Director | Open Market Purchase | 62,500 | 0.80 | 50,000.00 | +29,6% | |
| 2026-04-16 | ENO Robert Paul | Officer, President | Open Market Purchase | 12,500 | 0.80 | 10,000.00 | +5,9% | |
| 2026-04-16 | Cruickshank Tim | Officer, CFO | Open Market Purchase | 31,250 | 0.80 | 25,000.00 | +14,8% | |
| 2025-12-18 | de Urioste George | Director | Open Market Sale | -33,185 | 2.83 | -93,913.55 | -55,6% | |
| 2025-12-17 | STROME MARK E | 10% Owner | Open Market Sale | -250,000 | 3.58 | -895,000.00 | -529,6% | |
| 2025-12-17 | de Urioste George | Director | Open Market Sale | -23,961 | 3.68 | -88,176.48 | -52,2% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.